Shvetank Bhatt

Etazolate rescues behavioral deficits in chronic unpredictable mild stress model: Modulation of hypothalamic–pituitary–adrenal axis activity and brain-derived neurotrophic factor level

Ankur Jindal, Radhakrishnan Mahesh, Shvetank Bhatt · Neurochemistry International · 2013 · 49 citations

Hypothalamic Circuits, Psychoneuroimmunology, Stress Hormone +14

Type 4 phosphodiesterase enzyme inhibitor, rolipram rescues behavioral deficits in olfactory bulbectomy models of depression: Involvement of hypothalamic–pituitary–adrenal axis, cAMP signaling aspects and antioxidant defense system

Ankur Jindal, Radhakrishnan Mahesh, Shvetank Bhatt · Pharmacology Biochemistry and Behavior · 2015 · 30 citations

Phosphodiesterase Enzyme Inhibitor, Psychiatry, Behavioral Neuroscience +14

Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomy

Ankur Jindal, Radhakrishnan Mahesh, Shvetank Bhatt · Psychopharmacology · 2014 · 30 citations

Neurobiological Mechanism, Neuropsychology, Psychoactive Drug +15

Evaluation of anti-depressant-like activity of linezolid, an oxazolidinone class derivative – An investigation using behavioral tests battery of depression

Radhakrishnan Mahesh, Ankur Jindal, Baldev Gautam et al. · Biochemical and Biophysical Research Communications · 2011 · 24 citations

Psychoactive Drug, Psychiatry, Medicine +13

Antidepressant-like effect of etazolate, a cyclic nucleotide phosphodiesterase 4 inhibitor—an approach using rodent behavioral antidepressant tests battery

Ankur Jindal, Radhakrishnan Mahesh, Baldev Gautam et al. · European Journal of Pharmacology · 2012 · 23 citations

Psychoactive Drug, Psychiatry, Inhibitor—an Approach +14